COHERA MEDICAL TISSUGLU

FDA Premarket Approval P130023

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the tissuglu® surgical adhesive. This device is indicated for the approximation of tissue layers where subcutaneous dead space exists between the tissue planes in abdominoplasty.

DeviceCOHERA MEDICAL TISSUGLU
Generic NameTissue Adhesive For Internal Use
ApplicantCOHERA MEDICAL, INC
Date Received2013-11-12
Decision Date2015-02-03
Notice Date2015-02-04
PMAP130023
SupplementS
Product CodePJK 
Docket Number15M-0431
Advisory CommitteeGeneral & Plastic Surgery
Expedited ReviewNo
Combination Product No
Applicant Address COHERA MEDICAL, INC 209 Sandusky Street pittsburg, PA 15212
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P130023Original Filing
S005 2017-01-26 135 Review Track For 30-day Notice
S004
S003 2016-05-09 30-day Notice
S002 2016-02-02 Normal 180 Day Track No User Fee
S001 2015-06-18 Special (immediate Track)

NIH GUDID Devices

Device IDPMASupp
M690TG100US0 P130023 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.